Pediatric Vaccine
Survival analysis is helpful in assessing delay in age-appropriate vaccination
Published in Medical Letter on the CDC and FDA, May 3rd, 2006
According to recent research published in the American Journal of Epidemiology, "Assessment of delay in age-appropriate vaccination provides more information about timeliness of vaccination than up-to-date vaccination coverage. The authors applied survival analysis methods to data from a vaccination coverage survey among children aged 13-59 months conducted in Argentina in 2002. By age 19 months, 43% of children (95% confidence interval (CI): 40, 46) were vaccinated with the fourth dose of diphtheria, tetanus, and pertussis (DTP4)."
"By age 13 months, 55% of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Cancer Risk Factors
Wilms tumor is not linked to hazardous chemical exposure - Contraception
Progestogen-only contraceptives are safe for women with sickle cell anemia - Environmental Health
Oxidative metabolites of di(2-ethylhexyl) phthalate identified in humans - Helicobacter Pylori
Iron deficiency linked to Helicobacter pylori infection in Alaskan school children - Tuberculosis
Tuberculosis outbreak in childcare center in San Francisco is described - Acne
Survey suggests adults with acne scarring at a disadvantage at work and play - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
